• Article metrics
  • Last updated: Mon, 6 Dec 2021 15:45:05 GMT

Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?

Access & Citations

  • 981
    Article Accesses
  • Data not available
    Web of Science
  • Data not available

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

Online attention

Altmetric score 3
  • 5 tweeters
  • 19 Mendeley

This article is in the 57th percentile (ranked 110,570th) of the 276,294 tracked articles of a similar age in all journals and the 58th percentile (ranked 36th) of the 86 tracked articles of a similar age in Leukemia

View more on Altmetric

Altmetric calculates a score based on the online attention an article receives. Each coloured thread in the circle represents a different type of online attention. The number in the centre is the Altmetric score. Social media and mainstream news media are the main sources that calculate the score. Reference managers such as Mendeley are also tracked but do not contribute to the score. Older articles often score higher because they have had more time to get noticed. To account for this, Altmetric has included the context data for other articles of a similar age.